Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Omega-3 Fatty Acids for Treatment of Depression in Adolescents [Phase 3]
A Phase 3 trial evaluating omega-3 fatty acids for treating depression in adolescents has completed.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original application for a generic version of quetiapine fumarate from Sun Pharmaceutical Industries.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original-application generic quetiapine fumarate, a generic version of the antipsychotic queti…
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Follow-up Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder [Phase 2, Phase 3]
This document reports the completion of a follow-up study evaluating transcranial direct current stimulation for major depressive disorder i…
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (BluePoint Laboratories)
FDA approved the original application for quetiapine fumarate as a generic drug, with BluePoint Laboratories listed as the applicant.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Safety and Pharmacology Study of BMS-866949 [Phase 1]
A Phase 1 safety and pharmacology study of the investigational compound BMS-866949 in major depressive disorder was terminated.
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Working Toward Wellness [NA]
A MDRC-sponsored clinical trial called 'Working Toward Wellness' addressing depression has completed.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic quetiapine fumarate (ANDA 090120) via an Original Application approval. The generic is…
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Aurobindo Pharma Limited)
The FDA approved an original application for a generic quetiapine fumarate from Aurobindo Pharma Limited. This adds a generic option for the…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Site [Phase 4]
Phase 4 trial evaluating interpersonal psychotherapy for antepartum depression at three New York City sites has completed.
-
CLINICAL_TRIALS research · 2012-03-23Clinical Trial Update: A Non Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient With Major Depressive Disorder (MDD)
An observational, non-interventional study completed to investigate the ratio of misdiagnosed bipolar symptoms among patients with major dep…
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: A Study of Mood and Stress After Spinal Cord Injury
A completed clinical trial at the University of Michigan examined mood and stress after spinal cord injury in participants with depression.
-
CLINICAL_TRIALS research · 2012-03-20Clinical Trial Update: Comparison of Treatment Effect of Chinese Medicine and Western Medicine on Depression in China and America [NA]
A clinical trial comparing Chinese Medicine with Western Medicine for depression conducted in China and the United States. The current statu…
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Telephone Cognitive-Behavioral Therapy (CBT) for Subthreshold Depression and Presenteeism in Workplace [Phase 2, Phase 3]
This clinical trial update from Kyoto University reports on Telephone Cognitive-Behavioral Therapy for subthreshold depression and workplace…
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Patient Tolerability Study of GSK163090 [Phase 1]
GlaxoSmithKline completed a Phase 1 tolerability study of the investigational compound GSK163090 in adults with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Efficacy Study of Botox for Depression [Phase 4]
A Phase 4 clinical trial is evaluating the efficacy of Botox (onabotulinumtoxinA) for major depressive disorder, with the current study stat…
-
CLINICAL_TRIALS research · 2012-03-19Clinical Trial Update: Vascular Augmentation of Late-life Unremitted Depression (VALUeD) [Phase 3]
An update on the Phase 3 trial evaluating vascular augmentation for late-life unremitted depression (VALUeD).
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder [Phase 3]
Phase 3 study evaluating desvenlafaxine succinate sustained release (DVS SR) for major depressive disorder; results were posted after comple…
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: Low Field Magnetic Stimulation Treatment for Bipolar Depression [Phase 3]
Phase 3 trial evaluating Low Field Magnetic Stimulation for bipolar depression was terminated.
-
FDA approval · 2012-03-14FDA Approved: ESCITALOPRAM OXALATE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for a generic escitalopram oxalate product, expanding access to escitalopram …
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Integrating Depression Services Into DM Management [NA]
A completed clinical trial investigated integrating depression services into the management of Type 2 diabetes, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression [NA]
This trial evaluates the safety and feasibility of repetitive transcranial magnetic stimulation (rTMS) in adolescents with depression. The s…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Interpersonal Psychotherapy for Depressed Adolescents and Parents [Phase 1]
Phase 1 trial update shows completion of a study on interpersonal psychotherapy for depressed adolescents and parents. The snippet does not …
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Assessing Pain as a Mediator of Behavior Change in Post-coronary Angioplasty Patients
A completed clinical trial update examining whether pain mediates behavior change after coronary angioplasty, with attention to depressive s…
-
FDA approval · 2012-03-07FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth Pharmaceuticals (Pfizer).